NCT03744533

Brief Summary

Currently, the guideline recommended re-perfusion such as intravenous thrombolysis and mechanical thrombectomy as the most effective treatment for acute ischemic stroke. However, the two methods are restricted by a strict time window, which greatly limits the number of the patients receiving treatment. The abundant studies have suggested that good collateral circulation can provide compensatory blood supply to save the ischemic penumbra and reduces the infarct volume, which improves the prognosis. How to improve collateral circulation in an efficient and safe way is a clinical challenge. Our recent experiment results of the animal and preliminary clinical experiments show that head-down position may significantly increase cerebral perfusion and improve neurological function. Clinically, head-down position is simple and easy to operate, and theoretically may increases brain perfusion and improve collateral circulation. A pilot randomized clinical trial is designed to investigate the effect of head-down position combined with routine rehabilitation in patients with ischemic stroke.The study is designed to explore the efficacy and safety of head-down position in patients with acute ischemic stroke

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 14, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 16, 2018

Completed
10 days until next milestone

Study Start

First participant enrolled

November 26, 2018

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 28, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 28, 2021

Completed
Last Updated

September 28, 2021

Status Verified

September 1, 2021

Enrollment Period

2.8 years

First QC Date

November 14, 2018

Last Update Submit

September 26, 2021

Conditions

Keywords

head-down positionLarge Artery Atherosclerosis

Outcome Measures

Primary Outcomes (1)

  • proportion of modified Rankin Score of 0 to 2

    90 days

Secondary Outcomes (4)

  • Proportion of modified Rankin Score of 0 to 1

    90 days

  • proportion of early neurological deterioration

    48 hours

  • The occurence of stroke or other vascular events

    90 days

  • proportion of death of any cause

    90 days

Study Arms (2)

head-down position treatment

EXPERIMENTAL
Other: head-down position treatmentOther: guideline-based treatment

guideline-based treatment

ACTIVE COMPARATOR
Other: guideline-based treatment

Interventions

the head position of subjects is lowered to 20 degrees in a supine position between 8:00-22:00 within 24h post-randomization as long as possible. During the procedure, when subjects feel intolerable, the head position will be elevated to lying flat (0 degree) for 5-10min, and then the above procedure is repeated. After 24h post-randomization, the head down procedures with -20 degrees in a supine position with duration of 1-1.5 hour will be performed three times daily at 9:00-11:00, 15:00-17:00 and 20:00-22:00, respectively.

head-down position treatment

guideline-based treatment

guideline-based treatmenthead-down position treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient age over 18 years
  • acute ischemic stroke within 24 h of onset
  • neurological deficit: 6≤NIHSS≤16
  • Large artery atherosclerosis etiology based on TOAST typing
  • the supplied vessel is the middle cerebral artery or internal carotid artery, and the degree of stenosis was more than 50%.
  • first stroke onset or past stroke without obvious neurological deficit (mRS≤1)
  • Signed informed consent

You may not qualify if:

  • Disturbance of consciousness
  • Hemorrhagic stroke or mixed stroke
  • Combining with severe organ dysfunction
  • Past hemorrhagic stroke
  • A history of stroke with severe sequelae
  • Planned revascularization within 3 months
  • Ischemic stroke due to surgical intervention
  • participating in other clinical trials within 3 months
  • Pregnant or lactating women
  • any inappropriate patient assessed by the researcher

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

General Hospital of ShenYang Military Region

Shenyang, China

Location

Related Publications (1)

  • Chen HS, Zhang NN, Cui Y, Li XQ, Zhou CS, Ma YT, Zhang H, Jiang CH, Li RH, Wan LS, Jiao Z, Xiao HB, Li Z, Yan TG, Wang DL, Nguyen TN. A randomized trial of Trendelenburg position for acute moderate ischemic stroke. Nat Commun. 2023 May 5;14(1):2592. doi: 10.1038/s41467-023-38313-y.

MeSH Terms

Conditions

Ischemic Stroke

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Huisheng Chen, Doctor

    Neurology Department

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department Chairman

Study Record Dates

First Submitted

November 14, 2018

First Posted

November 16, 2018

Study Start

November 26, 2018

Primary Completion

August 28, 2021

Study Completion

August 28, 2021

Last Updated

September 28, 2021

Record last verified: 2021-09

Locations